{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:10:18Z","timestamp":1776100218821,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007440","name":"Hans-Bockler-Foundation","doi-asserted-by":"publisher","award":["414094"],"award-info":[{"award-number":["414094"]}],"id":[{"id":"10.13039\/501100007440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007440","name":"Hans-Bockler-Foundation","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100007440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007440","name":"Hans-Bockler-Foundation","doi-asserted-by":"publisher","award":["01GL2406A"],"award-info":[{"award-number":["01GL2406A"]}],"id":[{"id":"10.13039\/501100007440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kroner-Fresenius Foundation","doi-asserted-by":"publisher","award":["2020_EKSP.119"],"award-info":[{"award-number":["2020_EKSP.119"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpba.2025.116995","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:13:36Z","timestamp":1748344416000},"page":"116995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structure elucidation and quantification of the active pharmaceutical ingredient in a non-approved drug and in cat serum using QTRAP-MS\/MS and ZenoTOF-MS\/MS"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1320-4514","authenticated-orcid":false,"given":"Luke","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0873-9358","authenticated-orcid":false,"given":"Jeannie","family":"Horak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-1153","authenticated-orcid":false,"given":"Daniela","family":"Krentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0470-776X","authenticated-orcid":false,"given":"Katharina","family":"Zwicklbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-4329","authenticated-orcid":false,"given":"Eveline","family":"Lescrinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-1259","authenticated-orcid":false,"given":"Martin","family":"Alberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"von Both","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-7165","authenticated-orcid":false,"given":"Berthold","family":"Koletzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2025.116995_bib1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/tbed.13856","article-title":"Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): are they similar?","volume":"68","author":"Paltrinieri","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.jpba.2025.116995_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199059","article-title":"An updated review of feline coronavirus: mind the two biotypes","volume":"326","author":"Gao","year":"2023","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.jpba.2025.116995_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/01652176.2020.1845917","article-title":"Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats","volume":"40","author":"Izes","year":"2020","journal-title":"Vet. Q."},{"issue":"8","key":"10.1016\/j.jpba.2025.116995_bib4","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/v15081680","article-title":"Efficacy of oral remdesivir compared to GS-441524 for treatment of cats with naturally occurring effusive feline infectious peritonitis: a blinded, non-inferiority study","volume":"15","author":"Cosaro","year":"2023","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.jpba.2025.116995_bib5","first-page":"328","article-title":"Therapeutic effects of mutian((R)) Xraphconn on 141 client-owned cats with feline infectious peritonitis predicted by total bilirubin levels","volume":"8","author":"Katayama","year":"2021","journal-title":"Vet. Sci."},{"issue":"7","key":"10.1016\/j.jpba.2025.116995_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/rcm.7506","article-title":"Identification of metabolites of the novel anti-tumor drug candidate MDH-7 in rat urine by liquid chromatography coupled with triple quadrupole linear ion trap mass spectrometry","volume":"30","author":"Li","year":"2016","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"4","key":"10.1016\/j.jpba.2025.116995_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/19440049.2011.551947","article-title":"A novel approach to simultaneous screening and confirmation of regulated pharmaceutical compounds in dietary supplements by LC\/MS\/MS with an information-dependent acquisition method","volume":"28","author":"Lee","year":"2011","journal-title":"Food Addit. Contam.: Part A"},{"issue":"10","key":"10.1016\/j.jpba.2025.116995_bib8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/jms.1412","article-title":"Rapid screening and characterization of drug metabolites using a multiple ion monitoring-dependent MS\/MS acquisition method on a hybrid triple quadrupole-linear ion trap mass spectrometer","volume":"43","author":"Yao","year":"2008","journal-title":"J. Mass Spectrom."},{"issue":"7","key":"10.1016\/j.jpba.2025.116995_bib9","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00216-010-3485-2","article-title":"Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS\/MS system and library searching","volume":"396","author":"Dresen","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"issue":"6","key":"10.1016\/j.jpba.2025.116995_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/JLM.2009.057","article-title":"Simultaneous eicosanoid profiling and identification by liquid chromatography and hybrid triple quadrupole-linear ion trap mass spectrometry for metabolomic studies in human plasma","volume":"33","author":"Kortz","year":"2009","journal-title":"LaboratoriumsMedizin"},{"key":"10.1016\/j.jpba.2025.116995_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117023","article-title":"Forensic drug screening by liquid chromatography hyphenated with high-resolution mass spectrometry (LC-HRMS)","volume":"162","author":"Heinsvig","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2025.116995_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/ac5025649","article-title":"Autonomous metabolomics for rapid metabolite identification in global profiling","volume":"87","author":"Benton","year":"2015","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.jpba.2025.116995_bib13","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1038\/s41467-020-18171-8","article-title":"Ion mobility collision cross-section atlas for known and unknown metabolite annotation in untargeted metabolomics","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.jpba.2025.116995_bib14","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1021\/acs.analchem.3c01111","article-title":"Ultraviolet photodissociation permits comprehensive characterization of O-glycopeptides cleaved with O-glycoprotease IMPa","volume":"95","author":"Helms","year":"2023","journal-title":"Anal. Chem."},{"issue":"8","key":"10.1016\/j.jpba.2025.116995_bib15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/jasms.0c00425","article-title":"Dissociation of biomolecules by an intense low-energy electron beam in a high sensitivity time-of-flight mass spectrometer","volume":"32","author":"Baba","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"10","key":"10.1016\/j.jpba.2025.116995_bib16","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/acs.jproteome.2c00378","article-title":"Localization of multiple O-linked glycans exhibited in isomeric glycopeptides by hot electron capture dissociation","volume":"21","author":"Baba","year":"2022","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.jpba.2025.116995_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpba.2010.12.017","article-title":"Analytical challenges in drug counterfeiting and falsification-The NMR approach","volume":"55","author":"Holzgrabe","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116995_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113935","article-title":"Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS\/MS method in human serum","volume":"196","author":"Habler","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.jpba.2025.116995_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2023.2246553","article-title":"Quantification of GS-441524 concentration in feline plasma using high performance liquid chromatography with fluorescence detection","volume":"43","author":"Kimble","year":"2023","journal-title":"Vet. Q."},{"issue":"9","key":"10.1016\/j.jpba.2025.116995_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1515\/cclm-2020-0612","article-title":"Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient","volume":"58","author":"Alvarez","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.jpba.2025.116995_bib21","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkaa152","article-title":"Development and validation of a UHPLC-MS\/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2\/COVID-19 and Ebola virus disease","volume":"75","author":"Avataneo","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.jpba.2025.116995_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/v13112228","article-title":"Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524","volume":"13","author":"Krentz","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jpba.2025.116995_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00175254","article-title":"A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients","volume":"4","author":"Schleucher","year":"1994","journal-title":"J. Biomol. NMR"},{"issue":"2","key":"10.1016\/j.jpba.2025.116995_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0022-2364(92)90262-6","article-title":"Gradient-enhanced heteronuclear correlation spectroscopy. Theory and experimental aspects","volume":"100","author":"Ruiz-Cabello","year":"1992","journal-title":"J. Magn. Reson. (1969)"},{"issue":"13","key":"10.1016\/j.jpba.2025.116995_bib25","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116995_bib26","unstructured":"European Medicines Agency, Guideline on Bioanalytical Method Validation, (2011). \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf\u3009 (accessed 22 May 2025)."},{"issue":"W1","key":"10.1016\/j.jpba.2025.116995_bib27","doi-asserted-by":"crossref","first-page":"W94","DOI":"10.1093\/nar\/gku436","article-title":"CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra","volume":"42","author":"Allen","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpba.2025.116995_bib28","unstructured":"M.O.N.H. Clarke, E. Doerffler, R.L. Mackman, D. Siegel, Pyrrolo[1,2-f][1,2,4]Triazines Useful for Treating Respiratory Syncytial Virus Infections. Gilead Sciences, Inc.; 333 Lakeside Drive, Foster City, CA 94404, USA assignee. Patent WO2015069939A1. 2015."},{"key":"10.1016\/j.jpba.2025.116995_bib29","unstructured":"M.J. Perron, Methods of treating feline coronavirus infections. Gilead Sciences, Inc.; USA assignee. Patent WO2018169946A1. 2018."},{"key":"10.1016\/j.jpba.2025.116995_bib30","unstructured":"H. Hu, S. Zhang, Nucleosides salt and preparation method thereof. Jinan Mutian Biotechnology Co., Ltd. assignee. Patent WO2021022690A1. 2021."},{"key":"10.1016\/j.jpba.2025.116995_bib31","unstructured":"M. Hu, D. Hong, W. Xue, W. A kind of nucleoside compound containing six-membered ring and preparation method thereof. Nantong Weishun Biotechnology Co., Ltd. assignee. Patent CN111454270A. 2020."},{"key":"10.1016\/j.jpba.2025.116995_bib32","unstructured":"M. Hu, D. Hong, W. Xue, W. Six-membered ring-containing nucleoside compound and preparation method thereof. Nantong Weishun Biotechnology Co Ltd assignee. Patent US10988503B1. 2021."},{"issue":"7594","key":"10.1016\/j.jpba.2025.116995_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jpba.2025.116995_bib34","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/acs.oprd.3c00248","article-title":"Optimized Kilogram-Scale Synthesis and Impurity Identification of SHEN26 (ATV014) for Treating COVID-19","volume":"28","author":"Chen","year":"2023","journal-title":"Org. Process Res. Dev."},{"issue":"10","key":"10.1016\/j.jpba.2025.116995_bib35","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/jac\/dkaa239","article-title":"Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19","volume":"75","author":"Tempestilli","year":"2020","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852500336X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852500336X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:15:56Z","timestamp":1762308956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852500336X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S073170852500336X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116995","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure elucidation and quantification of the active pharmaceutical ingredient in a non-approved drug and in cat serum using QTRAP-MS\/MS and ZenoTOF-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116995"}}